Publications by authors named "Nehal Mohamed"

Claim this Profile
F
Formulation and characterization of tea tree and jojoba oils nano-emulgel for in-vivo wound healing assessment.
Nehal Kh Mohamed, Asmaa A Metwally, Sally M Y Fared, A Farid, Mohamed Taha

Colloids Surf B Biointerfaces· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luminescent Carbon Dots From Biomass Waste for the Sensitive Determination of Ascorbic Acid in Tablet Dosage Forms.
Nehal Mohamed, Mahmoud Hamed, Fotouh R Mansour, Walaa Zarad, Samy Emara

Luminescence· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extent of COVID-19 Healthcare Services of Isolation Center of Private Hospital across Khartoum State, Sudan.
Ghada Omer Hamad Abd El-Raheem, Maysoun Ahmed Awad Yousif, Doaa Salih Ibrahim Mohamed, Ragaa Omer Gasmelsaid Farah, Mohamed Elfatih Abdalla Bukhari, Nehal Faysal Ezalden Mohamed

J Environ Public Health· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.
Neeraj Agarwal, Arun Azad, Joan Carles, Simon Chowdhury, Bradley McGregor, Nehal Mohamed

Future Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup.
Heinz Ludwig, Meletios A Dimopoulos, Philippe Moreau, Wee-Joo Chng, Hartmut Goldschmidt, Nehal Mohamed

Leuk Lymphoma· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new potent phthalazine derivatives with VEGFR-2 and EGFR kinase inhibitory activity.
Kamilia M Amin, Flora F Barsoum, Fadi M Awadallah, Nehal E Mohamed

Eur J Med Chem· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
Meletios A Dimopoulos, Philippe Moreau, Antonio Palumbo, Douglas Joshua, Ludek Pour, Nehal Mohamed

Lancet Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A DeImmunized chimeric anti-C3b/iC3b monoclonal antibody enhances rituximab-mediated killing in NHL and CLL cells via complement activation.
Wu Peng, Xin Zhang, Nehal Mohamed, Giorgio Inghirami, Kenichi Takeshita

Cancer Immunol Immunother· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heteropolymers: a novel technology against blood-borne infections.
Nehal Mohamed, Steven M Jones, Leslie S Casey, Steven E Pincus, George L Spitalny

Curr Opin Mol Ther· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized Bacillus anthracis spore challenge.
Nehal Mohamed, Michelle Clagett, Juan Li, Steven Jones, Steven Pincus

Infect Immun· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages.
Nehal Mohamed, Juan Li, Claudia S Ferreira, Stephen F Little, Arthur M Friedlander

Infect Immun· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of antigen-based heteropolymer for treatment of systemic lupus erythematosus in a nonhuman primate model.
Steven E Pincus, Nadya Lukacher, Nehal Mohamed, Muctarr Sesay, Roger Zabinski

Clin Immunol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis